ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase,
and Increased Binding to Biglycan Diabetes September 2009 58:2018-2026; published ahead of print June 5, 2009, doi:10.2337/db09-0206